Construction and immune effect of Haemophilus parasuis DNA vaccine encoding glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in mice

Vaccine

Volumn 30, Issue 48, 2012, Pages 6839-6844

  Fu, Shulin ^a   Zhang, Minmin ^b   Ou, Jiwen ^a   Liu, Huazhen ^a   Tan, Chen ^a   Liu, Jinlin ^c   Chen, Huanchun ^a   Bei, Weicheng ^a  

^a HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c CENTRAL CHINA NORMAL UNIVERSITY   (China)

Author keywords

DNA vaccine; GAPDH; H. parasuis; Immune response; Protective efficacy

Indexed keywords

ANTIBODY; DNA VACCINE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAEMOPHILUS PARASUIS; IMMUNE RESPONSE; IMMUNIZATION; IN VIVO STUDY; KIDNEY; LIVER; MOUSE; MUSCLE; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; SPLEEN; TH1 CELL; TH2 CELL;

ANIMALS; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; DISEASE MODELS, ANIMAL; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HAEMOPHILUS INFECTIONS; HAEMOPHILUS PARASUIS; HAEMOPHILUS VACCINES; IMMUNOGLOBULIN G; MICE; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 84868194287     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.09.014     Document Type: Article

References (28)

1. Oliveira S., Pijoan C. Haemophilus parasuis: new trends on diagnosis, epidemiology and control. Vet Microbiol 2004, 99:1-12.
2. Rúbies X., Kielstein P., Costa L., Riera P., Artigas C., Espuña E. Prevalence of Haemophilus parasuis serovars isolated in Spain from 1993 to 1997. Vet Microbiol 1999, 66:245-248.
3. Kielstein P., Rapp-Gabrielson V.J. Designation of 15 serovars of Haemophilus parasuis on the basis of immunodiffusion using heat-stable antigen extracts. J Clin Microbiol 1992, 30:862-865.
4. Cai X., Chen H., Blackall P.J., Yin Z., Wang L., Liu Z., et al. Serological characterization of Haemophilus parasuis isolates from China. Vet Microbiol 2005, 232(111):231-236.
5. Zhou M., Guo Y., Zhao J., Hu Q., Hu Y., Zhang A., et al. Identification and characterization of novel immunogenic outer membrane proteins of Haemophilus parasuis serovar 5. Vaccine 2009, 27:5271-5277.
6. Tian H., Fu F., Li X., Chen X., Wang W., Lang Y., et al. Identification of the immunogenic outer membrane protein a antigen of Haemophilus parasuis by a proteomics approach and passive immunization with monoclonal antibodies in mice. Clin Vaccine Immunol 2011, 18(10):1695-1701.
7. Olvera A., Pina S., Pérez-Simó M., Aragón V., Segalés J., Bensaid A. Immunogenicity and protection against Haemophilus parasuis infection after vaccination with recombinant virulence associated trimeric autotransporters (VtaA). Vaccine 2011, 29:2797-2802.
8. Martínez S., Frandoloso R., Rodríguez-Ferri E.F., González-Zorn B., Gutiérrez-Martín C.B. Characterization of a recombinant transferrin-binding protein A (TbpA) fragment from Haemophilus parasuis serovar 5. FEMS Microbiol Lett 2010, 307:142-150.
9. Martínez-Martínez S., Frandoloso R., Gutiérrez-Martín C.B., Lampreave F., García-Iglesias M.J., Pérez-Martínez C., et al. Acute phase protein concentrations in colostrum-deprived pigs immunized with subunit and commercial vaccines against Glässer's disease. Vet Immunol Immunopathol 2011, 144:61-67.
10. Svennerholm A.M., Lundgren A. Recent progress toward an enterotoxigenic Escherichia coli vaccine. Expert Rev Vaccines 2012, 11(4):495-507.
11. Chiang C.H., Huang W.F., Huang L.P., Lin S.F., Yang W.J. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model. Vaccine 2009, 27:4565-4570.
12. Sun Y., Hu Y.H., Liu C.S., Sun L. Construction and analysis of an experimental Streptococcus iniae DNA vaccine. Vaccine 2010, 28:3905-3912.
13. Borrego B., Argilaguet J.M., Pérez-Martín E., Dominguez J., Pérez-Filgueira M., Escribano J.M., et al. A DNA vaccine encoding foot-and-mouth disease virus B and T-cell epitopes targeted to class II swine leukocyte antigens protects pigs against viral challenge. Antiviral Res 2011, 92(2):359-363.
14. Doroud D., Vatanara A., Zahedifard F., Gholami E., Vahabpour R., Najafabadi A.R., et al. Cationic solid lipid nanoparticles loaded by cystein proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations. J Control Release 2010, 148:105-111.
15. Ingolotti M., Kawalekar O., Shedlock D.J., Muthumani K., Weiner D.B. DNA vaccines for targeting bacterial infections. Expert Rev Vaccines 2010, 9(7):747-763.
16. Ferraro B., Morrow M.P., Hutnick N.A., Shin T.H., Lucke C.E., Weiner D.B. Clinical applications of DNA vaccines: current progress. Clin Infect Dis 2011, 53(3):296-302.
17. Kim J.W., Dang C.V. Multifaceted roles of glycolytic enzymes. Trends Biochem 2005, 30:142-150.
18. Madureira P., Baptista M., Vieira M., Magalhães V., Camelo A., Oliveira L., et al. Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol 2007, 178(3):1379-1387.
19. Lu Y.C., Li M.C., Chen Y.M., Chu C.Y., Lin S.F., Yang W.J. DNA vaccine encoding type IV pilin of Actinobacillus pleuropneumoniae induces strong immune response but confers limited protective efficacy against serotype 2 challenge. Vaccine 2011, 29:7740-7746.
20. Furano K., Campagnari A.A. Inactivation of the Moraxella catarrhalis 7169 ferric uptake regulator increases susceptibility to the bactericidal activity of normal human sera. Infect Immun 2003, 71(4):1843-1848.
21. Sun Y., Liu C.S., Sun L. Construction and analysis of the immune effect of an Edwardsiella tarda DNA vaccine encoding a D15-like surface antigen. Fish Shellfish Immunol 2011, 30:273-279.
22. Yuan F., Fu S., Hu J., Li J., Chang H., Hu L., et al. Evaluation of recombinant proteins of Haemophilus parasuis strain SH0165 as vaccine candidates in a mouse model. Res Vet Sci 2012, 93(1):51-56.
23. Zhang B., Xu C., Zhou S., Feng S., Zhang L., He Y., et al. Comparative proteomic analysis of a Haemophilus parasuis SC096 mutant deficient in the outer membrane protein P5. Microb Pathogenesis 2012, 52(2):117-124.
24. Zhang B., Feng S., Xu C., Zhou S., He Y., Zhang L., et al. Serum resistance in Haemophilus parasuis SC096 strain requires outer membrane protein P2 expression. FEMS Microbiol Lett 2012, 326:109-115.
25. Saade F., Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2012, 11(2):189-209.
26. Zhao Y., Liu Q., Wang X., Zhou L., Wang Q., Zhang Y. Surface display of Aeromonas hydrophila GAPDH in attenuated Vibrio anguillarum to develop a noval multivalent vector vaccine. Mar Biotechnol 2011, 10:1007-1015.
27. Santema W., Hensen S., Rutten V., Koets A. Heat shock protein 70 subunit vaccination against bovine paratuberculosis does not interfere with current immunodiagnostic assays for bovine tuberculosis. Vaccine 2009, 27(17):2312-2319.
28. Fu S., Yuan F., Zhang M., Tan C., Chen H., Bei W. Cloning, expression and characterization of a cell wall surface protein, 6-phosphogluconate dehydrogenase, of Haemophilus parasuis. Res Vet Sci 2012, 93(1):57-62.